The Moving Average Convergence Divergence (MACD) for CON turned positive on October 05, 2026. Looking at past instances where CON's MACD turned positive, the stock continued to rise in 14 of 18 cases over the following month. The odds of a continued upward trend are 78%.
The Momentum Indicator moved above the 0 level on October 02, 2026. You may want to consider a long position or call options on CON as a result. In 29 of 45 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 64%.
Following a +3.12% 3-day Advance, the price is estimated to grow further. Considering data from situations where CON advanced for three days, in 96 of 131 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
The Aroon Indicator entered an Uptrend today. In 52 of 85 cases where CON Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 61%.
The 10-day RSI Indicator for CON moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 16 similar instances where the indicator moved out of overbought territory. In 8 of the 16 cases, the stock moved lower in the following days. This puts the odds of a move lower at 50%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CON declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.
CON broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 21 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. CON’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 67 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.285) is normal, around the industry mean (204.532). P/E Ratio (27.239) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.006) settles around the average of (0.154) among similar stocks. P/S Ratio (2.035) is also within normal values, averaging (2.688).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CON’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
The Moving Average Convergence Divergence (MACD) for MD turned positive on October 08, 2026. Looking at past instances where MD's MACD turned positive, the stock continued to rise in 35 of 45 cases over the following month. The odds of a continued upward trend are 78%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on MD as a result. In 71 of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.
MD moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MD crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 61%.
Following a +5.24% 3-day Advance, the price is estimated to grow further. Considering data from situations where MD advanced for three days, in 193 of 297 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
The Aroon Indicator entered an Uptrend today. In 134 of 198 cases where MD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 68%.
The 10-day RSI Indicator for MD moved out of overbought territory on November 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In 23 of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at 85%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 42 of 59 cases where MD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 71%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
MD broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. MD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 46 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 60 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.886) is normal, around the industry mean (204.532). P/E Ratio (14.690) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.120) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (1.119) is also within normal values, averaging (2.688).
The Tickeron Profit vs. Risk Rating rating for this company is 83 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
MD | ||
|---|---|---|
OUTLOOK RATING 1..100 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 60 Fair valued | |
PROFIT vs RISK RATING 1..100 | 83 | |
SMR RATING 1..100 | 46 | |
PRICE GROWTH RATING 1..100 | 37 | |
P/E GROWTH RATING 1..100 | 17 | |
SEASONALITY SCORE 1..100 | 3 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| CON | MD | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 50% | 4 days ago 85% |
| Stochastic ODDS (%) | 4 days ago 57% | 4 days ago 71% |
| Momentum ODDS (%) | 7 days ago 64% | 4 days ago 74% |
| MACD ODDS (%) | 6 days ago 78% | 4 days ago 78% |
| TrendWeek ODDS (%) | 4 days ago 65% | 4 days ago 65% |
| TrendMonth ODDS (%) | 4 days ago 68% | 4 days ago 65% |
| Advances ODDS (%) | 12 days ago 73% | 8 days ago 65% |
| Declines ODDS (%) | 7 days ago 63% | 4 days ago 70% |
| BollingerBands ODDS (%) | 4 days ago 57% | 4 days ago 76% |
| Aroon ODDS (%) | 4 days ago 61% | 4 days ago 68% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CON’s FA Score shows that 2 FA rating(s) are green while MD’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CON’s TA Score shows that 4 TA indicator(s) are bullish while MD’s TA Score has 6 bullish TA indicator(s).
CON (@Hospital/Nursing Management) experienced а +4.56% price change this week, while MD (@Hospital/Nursing Management) price change was +4.93% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -2.34%. For the same industry, the average monthly price growth was +2.28%, and the average quarterly price growth was +11.65%.
MD is expected to report earnings on Feb 18, 2027.
Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
A.I.dvisor indicates that over the last year, CON has been loosely correlated with PNTG. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CON jumps, then PNTG could also see price increases.
| Ticker / NAME | Correlation To CON | 1D Price Change % | ||
|---|---|---|---|---|
| CON | 100% | +0.17% | ||
| PNTG - CON | 45% Loosely correlated | -9.10% | ||
| UHS - CON | 40% Loosely correlated | -1.56% | ||
| AVAH - CON | 38% Loosely correlated | -3.07% | ||
| THC - CON | 38% Loosely correlated | -1.09% | ||
| HCSG - CON | 36% Loosely correlated | -3.31% | ||
More | ||||
A.I.dvisor indicates that over the last year, MD has been loosely correlated with UHS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if MD jumps, then UHS could also see price increases.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CSEN | 24.61 | 0.28 | +1.15% |
| Cohen & Steers Future of Energy Active ETF (CSEN) | |||
| VIOO | 128.08 | 0.09 | +0.07% |
| Vanguard S&P Small-Cap 600 ETF (VIOO) | |||
| IBHG | 21.67 | -0.02 | -0.09% |
| iShares iBonds 2027 Term High Yield and Income ETF (IBHG) | |||
| PDDL | 11.84 | -0.31 | -2.55% |
| GraniteShares 2x Long PDD Daily ETF (PDDL) | |||
| CFND | 2.20 | -0.07 | -3.08% |
| C1 Fund Inc | |||